Clinical trial
CHOlesterol Lowering and Residual Risk in Type 2 Diabetes
NCT04369664 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CHOlesterol Lowering and Residual Risk in Type 2 Diabetes
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 12, 2020
- Completion date
- October 19, 2023
- Enrollment
- 151 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes